Literature DB >> 19670250

The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells.

Tobias D Henning1, Elizabeth J Sutton, Anne Kim, Daniel Golovko, Andrew Horvai, Larry Ackerman, Barbara Sennino, Donald McDonald, Jeffrey Lotz, Heike E Daldrup-Link.   

Abstract

For in vivo applications of magnetically labeled stem cells, biological effects of the labeling procedure have to be precluded. This study evaluates the effect of different ferucarbotran cell labeling protocols on chondrogenic differentiation of human mesenchymal stem cells (hMSC) as well as their implications for MR imaging. hMSC were labeled with ferucarbotran using various protocols: cells were labeled with 100 microg Fe/ml for 4 and 18 h and additional samples were cultured for 6 or 12 days after the 18 h labeling. Supplementary samples were labeled by transfection with protamine sulfate. Iron uptake was quantified by ICP-spectrometry and labeled cells were investigated by transmission electron microscopy and by immunostaining for ferucarbotran. The differentiation potential of labeled cells was compared with unlabeled controls by staining with Alcian blue and Hematoxylin and Eosin, then quantified by measurements of glucosaminoglycans (GAG). Contrast agent effect at 3 T was investigated on days 1 and 14 of chondrogenic differentiation by measuring signal-to-noise ratios on T(2)-SE and T(2)*-GE sequences. Iron uptake was significant for all labeling protocols (p < 0.05). The uptake was highest after transfection with protamine sulfate (25.65 +/- 3.96 pg/cell) and lowest at an incubation time of 4 h without transfection (3.21 +/- 0.21 pg/cell). While chondrogenic differentiation was decreased using all labeling protocols, the decrease in GAG synthesis was not significant after labeling for 4 h without transfection. After labeling by simple incubation, chondrogenesis was found to be dose-dependent. MR imaging showed markedly lower SNR values of all labeled cells compared with the unlabeled controls. This contrast agent effect persisted for 14 days and the duration of differentiation. Magnetic labeling of hMSC with ferucarbotran inhibits chondrogenesis in a dose-dependent manner when using simple incubation techniques. When decreasing the incubation time to 4 h, inhibition of chondrogenesis was not significant. Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19670250      PMCID: PMC2933782          DOI: 10.1002/cmmi.276

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  46 in total

1.  Tissue-engineered bone regeneration.

Authors:  H Petite; V Viateau; W Bensaïd; A Meunier; C de Pollak; M Bourguignon; K Oudina; L Sedel; G Guillemin
Journal:  Nat Biotechnol       Date:  2000-09       Impact factor: 54.908

Review 2.  Mesenchymal stem cells: biology and potential clinical uses.

Authors:  R J Deans; A B Moseley
Journal:  Exp Hematol       Date:  2000-08       Impact factor: 3.084

3.  Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells.

Authors:  Kathleen A Hinds; Jonathan M Hill; Erik M Shapiro; Mikko O Laukkanen; Alfonso C Silva; Christian A Combs; Timothy R Varney; Robert S Balaban; Alan P Koretsky; Cynthia E Dunbar
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

4.  A new technique to expand human mesenchymal stem cells using basement membrane extracellular matrix.

Authors:  Takehiro Matsubara; Shinichi Tsutsumi; Haiou Pan; Hisatada Hiraoka; Ryo Oda; Masahiro Nishimura; Hiroshi Kawaguchi; Kouzou Nakamura; Yukio Kato
Journal:  Biochem Biophys Res Commun       Date:  2004-01-16       Impact factor: 3.575

5.  Stem cell therapy in a caprine model of osteoarthritis.

Authors:  J Mary Murphy; David J Fink; Ernst B Hunziker; Frank P Barry
Journal:  Arthritis Rheum       Date:  2003-12

Review 6.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.

Authors:  Y X Wang; S M Hussain; G P Krestin
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

7.  Targeting of hematopoietic progenitor cells with MR contrast agents.

Authors:  Heike E Daldrup-Link; Martina Rudelius; Robert A J Oostendorp; Marcus Settles; Guido Piontek; Stefan Metz; Hilkea Rosenbrock; Ulrich Keller; Ulrich Heinzmann; Ernst J Rummeny; Jürgen Schlegel; Thomas M Link
Journal:  Radiology       Date:  2003-07-24       Impact factor: 11.105

8.  Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat.

Authors:  Mathias Hoehn; Ekkehard Küstermann; James Blunk; Dirk Wiedermann; Thorsten Trapp; Stefan Wecker; Melanie Föcking; Heinz Arnold; Jürgen Hescheler; Bernd K Fleischmann; Wolfram Schwindt; Christian Bührle
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-20       Impact factor: 11.205

Review 9.  Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications.

Authors:  Peter Reimer; Thomas Balzer
Journal:  Eur Radiol       Date:  2002-11-01       Impact factor: 5.315

10.  Highly efficient paramagnetic labelling of embryonic and neuronal stem cells.

Authors:  Martina Rudelius; Heike E Daldrup-Link; Ulrich Heinzmann; Guido Piontek; Marcus Settles; Thomas M Link; Jürgen Schlegel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-04       Impact factor: 9.236

View more
  36 in total

1.  Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles.

Authors:  Dorota A Kedziorek; Naser Muja; Piotr Walczak; Jesus Ruiz-Cabello; Assaf A Gilad; Chunfa C Jie; Jeff W M Bulte
Journal:  Magn Reson Med       Date:  2010-04       Impact factor: 4.668

2.  In vivo magnetic resonance imaging and optical imaging comparison of viable and nonviable mesenchymal stem cells with a bifunctional label.

Authors:  Elizabeth Jane Sutton; Tobias D Henning; Sophie Boddington; Stavros Demos; Christian Krug; Reinhardt Meier; John Kornak; Shoujun Zhao; Rick Baehner; Sheida Sharifi; Heike Daldrup-Link
Journal:  Mol Imaging       Date:  2010-10       Impact factor: 4.488

Review 3.  The application of super paramagnetic iron oxide-labeled mesenchymal stem cells in cell-based therapy.

Authors:  Yiying Qi; Gang Feng; Zhongming Huang; Weiqi Yan
Journal:  Mol Biol Rep       Date:  2012-12-27       Impact factor: 2.316

4.  Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis.

Authors:  Stacey M Cromer Berman; C Joanne Wang; Inema Orukari; Andre Levchenko; Jeff W M Bulte; Piotr Walczak
Journal:  Magn Reson Med       Date:  2012-02-28       Impact factor: 4.668

5.  Bifunctional Labeling of Rabbit Mesenchymal Stem Cells for MR Imaging and Fluorescence Microscopy.

Authors:  Markus T Berninger; Pablo Rodriguez-Gonzalez; Franz Schilling; Bernhard Haller; Thorsten Lichtenstein; Andreas B Imhoff; Ernst J Rummeny; Martina Anton; Stephan Vogt; Tobias D Henning
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

6.  Magnetization transfer imaging provides a quantitative measure of chondrogenic differentiation and tissue development.

Authors:  Weiguo Li; Liu Hong; Liping Hu; Richard L Magin
Journal:  Tissue Eng Part C Methods       Date:  2010-05-10       Impact factor: 3.056

7.  Direct labeling of hMSC with SPIO: the long-term influence on toxicity, chondrogenic differentiation capacity, and intracellular distribution.

Authors:  Chung-Yi Yang; Jong-Kai Hsiao; Ming-Fong Tai; Shin-Tai Chen; Hui-Ying Cheng; Jaw-Lin Wang; Hon-Man Liu
Journal:  Mol Imaging Biol       Date:  2011-06       Impact factor: 3.488

8.  Labeling stem cells with ferumoxytol, an FDA-approved iron oxide nanoparticle.

Authors:  Rosalinda T Castaneda; Aman Khurana; Ramsha Khan; Heike E Daldrup-Link
Journal:  J Vis Exp       Date:  2011-11-04       Impact factor: 1.355

9.  Iron administration before stem cell harvest enables MR imaging tracking after transplantation.

Authors:  Aman Khurana; Fanny Chapelin; Graham Beck; Olga D Lenkov; Jessica Donig; Hossein Nejadnik; Solomon Messing; Nikita Derugin; Ray Chun-Fai Chan; Amitabh Gaur; Barbara Sennino; Donald M McDonald; Paul J Kempen; Grigory A Tikhomirov; Jianghong Rao; Heike E Daldrup-Link
Journal:  Radiology       Date:  2013-07-12       Impact factor: 11.105

10.  Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI.

Authors:  Aman Khurana; Hossein Nejadnik; Fanny Chapelin; Olga Lenkov; Rakhee Gawande; Sungmin Lee; Sandeep N Gupta; Nooshin Aflakian; Nikita Derugin; Solomon Messing; Guiting Lin; Tom F Lue; Laura Pisani; Heike E Daldrup-Link
Journal:  Nanomedicine (Lond)       Date:  2013-03-27       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.